Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. K. (Karina) Meijer

Publicaties

Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants

Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism

Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients

De combinatiepil is geen goede keuze (meer) voor 35-plussers

Effect of previous INR control during VKA therapy on subsequent DOAC adherence and persistence, in patients switched from VKA to DOAC

Ethical aspects of hemophilia gene therapy: a qualitative interview study with stakeholders

Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression

Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Lees meer

Pers/media

Na je 40e vergroot de anticonceptiepil de kans op trombose

Zorgen over anticonceptiepil na 35ste

Dit wil je weten over de bijwerkingen van bloedverdunners

Gentherapie als wapen tegen hemofilie B

Drie patiënten genezen van hemofilie B na onderzoek in UMCG

Hoop voor hemofilie B patiënten door nieuwe gentherapie

NVHP webinars terugkijken

Kijk terug: webinar gentherapie en webinar Hemofilie in Nederland

Lees meer